These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29885036)

  • 1. Role of sublingual immunotherapy in the treatment of asthma: An updated systematic review.
    Lin SY; Azar A; Suarez-Cuervo C; Diette GB; Brigham E; Rice J; Ramanathan M; Robinson KA
    Int Forum Allergy Rhinol; 2018 Sep; 8(9):982-992. PubMed ID: 29885036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergen-Specific Immunotherapy in the Treatment of Pediatric Asthma: A Systematic Review.
    Rice JL; Diette GB; Suarez-Cuervo C; Brigham EP; Lin SY; Ramanathan M; Robinson KA; Azar A
    Pediatrics; 2018 May; 141(5):. PubMed ID: 29572287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
    Virchow JC; Backer V; Kuna P; Prieto L; Nolte H; Villesen HH; Ljørring C; Riis B; de Blay F
    JAMA; 2016 Apr; 315(16):1715-25. PubMed ID: 27115376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease.
    Emminger W; Hernández MD; Cardona V; Smeenk F; Fogh BS; Calderon MA; de Blay F; Backer V
    Int Arch Allergy Immunol; 2017; 174(1):35-44. PubMed ID: 28950268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets.
    Nolte H; Casale TB; Lockey RF; Fogh BS; Kaur A; Lu S; Nelson HS
    J Allergy Clin Immunol Pract; 2017; 5(1):84-89.e3. PubMed ID: 27838323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sublingual immunotherapy for allergic asthma: retrospective meta-analysis of randomized, double-blind and placebo-controlled trials.
    Tao L; Shi B; Shi G; Wan H
    Clin Respir J; 2014 Apr; 8(2):192-205. PubMed ID: 24118881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
    Lin SY; Erekosima N; Kim JM; Ramanathan M; Suarez-Cuervo C; Chelladurai Y; Ward D; Segal JB
    JAMA; 2013 Mar; 309(12):1278-88. PubMed ID: 23532243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A Meta-analysis of efficacy and safety of sublingual immunotherapy on allergic asthma].
    Wu YY; Xie XM; Han D; Li SJ; Liu L; Li MX
    Zhonghua Nei Ke Za Zhi; 2013 Oct; 52(10):844-8. PubMed ID: 24378062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversies in Allergy: A Pro/Con Review of Sublingual Allergen Immunotherapy and Allergic Asthma.
    Calderón MA; Bacharier LB
    J Allergy Clin Immunol Pract; 2021 May; 9(5):1818-1825. PubMed ID: 33652134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
    Chelladurai Y; Suarez-Cuervo C; Erekosima N; Kim JM; Ramanathan M; Segal JB; Lin SY
    J Allergy Clin Immunol Pract; 2013; 1(4):361-9. PubMed ID: 24565541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
    Hesse L; Nawijn MC
    Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites.
    Maloney J; Prenner BM; Bernstein DI; Lu S; Gawchik S; Berman G; Kaur A; Li Z; Nolte H
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):59-65. PubMed ID: 26553448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Sublingual Immunotherapy on Airway Inflammation and Airway Wall Thickness in Allergic Asthma.
    Hoshino M; Akitsu K; Kubota K
    J Allergy Clin Immunol Pract; 2019; 7(8):2804-2811. PubMed ID: 31228618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.
    Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S
    J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases.
    Ferrando M; Bagnasco D; Passa-Lacqua G; Puggioni F; Varricchi G; Canonica GW
    Curr Pharm Biotechnol; 2017; 18(5):378-383. PubMed ID: 28413977
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.